Impact of Ocrelizumab on Cognition in Patients at Increased Risk of Progressive Disease (P1.420)
Year: 2018
Type: article
Source: Neurology
Institutions: University at Buffalo, State University of New York, Hôpitaux Universitaires de Strasbourg, University of California, San Francisco, University of Basel, University Hospital of Basel, The University of Texas Health Science Center at Houston, Genentech, F. Hoffmann-La Roche AG, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2802044471
